A H + Rare earth inorganic nanoluminescent material with enhanced luminescence by ion doping and preparation method and application thereof
By introducing H+ ions as crystal field perturbants in rare earth inorganic nanomaterials, the problems of low quantum yield and fluorescence quenching during the upconversion process are solved, the luminescence intensity is improved and biosafety is maintained, and it is suitable for biological body. Fluorescent labeling application.
Patent Information
- Application Number
- CN202111248340.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-10-26
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2041-10-26
AI Technical Summary
The existing rare earth-doped inorganic nanomaterials have problems with low quantum yield and fluorescence quenching during the upconversion process, resulting in limited improvement in luminescence intensity and large doped ions leading to lattice defects, affecting the application in vivo of biological organisms.
By introducing H+ ions as perturbants in rare earth inorganic nanomaterials, the 4f-4f transition ban in rare earth ions in high symmetry environments is partially lifted, and the luminescence intensity is improved. Metal fluoride matrix and H+ doped rare earth ions are used to use metal fluoride matrix and H+ doped rare earth ions. The nanoluminescent material constructed is provided with an acidic solution to achieve H+ introduction in the crystal.
It significantly improves the luminescence intensity of rare earth-doped inorganic nanomaterials, maintains the chemical stability and biosafety of the materials, broadens the application range, and shows excellent optical properties especially in fluorescent labeling applications in biological bodies.
Smart Images

Figure CN116023944B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of optical nanomaterials and specifically relates to a H + Rare earth inorganic nanoluminescent material with ion doping enhanced luminescence, preparation method and application thereof. Background Art
[0002] With the development of nanosynthesis technology, trivalent rare earth ions (Ln 3+ )-doped nanomaterials have gradually shown great application potential in the fields of biomarkers, solar cells, cancer phototherapy and three-dimensional display. Compared with the shortcomings of quantum dots and organic dyes such as toxicity, instability and susceptibility to environmental interference, rare earth-doped inorganic nanomaterials have the advantages of high chemical stability, low toxicity, weak fluorescence background and high time resolution, and are gradually becoming popular in the research of biomedicine. Rare earth-doped inorganic nanomaterials usually have two luminescence modes: upconversion and downtransfer. The upconversion is an anti-Stokes process, that is, the energy of the emitted photon is higher than the energy of the incident photon. The complex upconversion process and the high specific surface area of nanomaterials make the quantum yield of this type of material much lower than that of traditional fluorescent materials. In order to improve this problem, people have carried out research on different synergistic schemes.
[0003] Among various research schemes, the most commonly used scheme is to construct a core-shell structure to reduce the influence of the external environment and surface defects of nanocrystals on the upconversion efficiency of the crystal. However, constructing a core-shell structure is not only cumbersome, but also leads to an increase in the size of the nanocrystals, which is not conducive to the application of nanocrystals in vivo. Another commonly used scheme is to affect the Ln 3+ The crystal field environment inside the crystal is used to improve the upconversion efficiency of the crystal, which is called doping enhancement method. The doping enhancement method is to reduce the local symmetry of the crystal by introducing transition elements or alkali metal elements into the inorganic rare earth doping material, partially lift the 4f-4f transition prohibition of the rare earth ion, and thus improve the luminescence intensity of the material. However, most of the doped rare earth ions have a large ion radius, which will reduce the symmetry of the crystal field while also bringing a large number of lattice defects, forming fluorescence quenching centers. When the energy of the luminescence center is transferred to the quenching center, it will inevitably bring energy loss, causing fluorescence quenching. Therefore, the degree of improvement in the luminescence intensity in the doping enhancement method is limited due to the influence of the doping concentration of the doped ions. Summary of the invention
[0004] In order to improve the above technical problems, the present invention provides a H + Rare earth inorganic nanoluminescent material with enhanced luminescence by ion doping, the chemical composition of the nanoluminescent material is A a R b F c:xB / H, where A a R b F c is the matrix, B is the doped rare earth ion, x is the percentage of doped rare earth ions, H + The ions are perturbing agents of the crystal field, the x is 2% to 30%, and the a, b, and c are determined according to the valence states of A and R.
[0005] Preferably, the nano luminescent material is nanoparticles.
[0006] Preferably, the nanoparticles are crystalline, and the crystal structure is an orthorhombic phase, such as a pure orthorhombic phase.
[0007] According to an embodiment of the present invention, the size of the nanoparticles is 5-25 nm, preferably 10-20 nm, more preferably 12-16 nm, for example 6.7 nm, 9.0 nm, 12.3 nm, 12.5 nm, 16.9 nm, 18.3 nm.
[0008] According to an embodiment of the present invention, the A a R b F c It is a metal fluoride with lattice gaps, wherein A is an alkali metal element selected from lithium (Li), sodium (Na), potassium (K), rubidium (Rb) or cesium (Cs); and R is an alkaline earth metal element or a transition metal element selected from magnesium (Mg), zinc (Zn), zirconium (Zr) or scandium (Sc).
[0009] Preferably, the metal fluoride A having lattice gaps a R b F c NaMgF3, NaZnF3, Na3ZrF7, Na7Zr6F 31 , KSc2F7, more preferably NaMgF3.
[0010] According to an embodiment of the present invention, the doped rare earth ion B is selected from one or more of Yb, Er, Tm, Ho, Gd, Eu, Tb, Sm, Dy, Ce and Nd, preferably Yb, Er, Tm, Ho, Nd, more preferably Yb and Er are co-doped, Er is used as the rare earth luminescence center, and Yb is used as a rare earth luminescence sensitizer.
[0011] According to an embodiment of the present invention, the structural formula of the nano luminescent material is selected from the group consisting of NaMgF3:Yb / Er / H, NaZnF3:Yb / Er / H, Na3ZrF7:Yb / Er / H, Na7Zr6F 31 :Yb / Er / H, KSc2F7:Yb / Er / H, for example, NaMgF3:Yb / Er / H.
[0012] According to an embodiment of the present invention, the nanomaterial has substantially Figure 3 Transmission electron microscopy image shown in a.
[0013] According to an embodiment of the present invention, the nanomaterial has substantially Figure 3 XRD pattern shown in b.
[0014] According to an embodiment of the present invention, the nanomaterial has substantially Figure 3 c The high-angle annular dark field imaging image described above.
[0015] According to an embodiment of the present invention, the nanomaterial has substantially Fig. 9 The up-conversion emission spectrum is shown (excitation wavelength is 980 nm).
[0016] According to an embodiment of the present invention, the nanomaterial has substantially Fig.11 The near-infrared emission spectrum (excitation wavelength is 980 nm) is shown.
[0017] The present invention also provides a kind of H + The method for synthesizing a rare earth inorganic nanomaterial with doped and enhanced luminescence comprises the following steps:
[0018] 1) preparing an alkaline earth metal or transition metal and rare earth mixed precursor solution a and an alkali metal fluoride precursor solution b;
[0019] 2) Adding alkaline earth metal or transition metal and rare earth mixed precursor a and alkali metal fluoride precursor b into an acidic solution to react and obtain H + Rare earth doped inorganic nanomaterials.
[0020] According to an embodiment of the present invention, the step 2) of adding the alkaline earth metal or transition metal and rare earth mixed precursor a and the alkali metal fluoride precursor b to the acidic solution for reaction includes mixing the alkaline earth metal or transition metal and rare earth mixed precursor a and the alkali metal fluoride precursor b under an inert atmosphere, removing methanol, injecting the acidic solution, heating to 270-340°C, keeping the temperature for 0.5-1.5h to react, cooling, and centrifuging to obtain a precipitate.
[0021] Preferably, the reaction temperature is 290-320° C., and the insulation time is 45-100 min. More preferably, the reaction temperature is 300-310° C., and the insulation time is 50-70 min.
[0022] For example, the reaction temperature is 275°C, 280°C, 285°C, 290°C, 300°C, 310°C, 320°C, 330°C, or 340°C.
[0023] For example, the reaction time is 45 min, 60 min, 70 min, 80 min, 90 min, or 100 min.
[0024] According to an embodiment of the present invention, the step of removing methanol comprises: heating the mixed solution to 60-100° C. and keeping the temperature for 20-50 min. Preferably, heating the mixed solution to 70-80° C. and keeping the temperature for 30-45 min.
[0025] For example, the temperature after heating is 65°C, 70°C, 75°C, 80°C, or 85°C; and the insulation time is 30 min, 35 min, 40 min, or 50 min.
[0026] According to an embodiment of the present invention, the acidic solution is selected from one, two or more of acetic acid, hydrochloric acid, phenylcyclic acid and formic acid, such as acetic acid or phenylcyclic acid.
[0027] According to an embodiment of the present invention, a washing step is further included after obtaining the precipitate.
[0028] According to an embodiment of the present invention, the washing further includes the steps of centrifugal separation and purification.
[0029] According to an embodiment of the present invention, the preparation of the alkaline earth metal (transition metal) and rare earth mixed precursor a in step 1) comprises: mixing a rare earth source, a long alkane chain organic acid, trioctylamine, an alkaline earth metal source or a transition metal source until dissolved to obtain a precursor solution a;
[0030] According to an embodiment of the present invention, the mixing comprises heating to 140-165° C. under the protection of an inert atmosphere, and stirring for 0.3-1 h until dissolved.
[0031] Preferably, the heating temperature is 145-160°C, more preferably, the heating temperature is 150-160°C, for example, 140°C, 145°C, 150°C, 155°C, 160°C or 165°C.
[0032] Preferably, the stirring time is 0.5-1 h, for example, 20 min, 30 min, 40 min, 50 min or 60 min.
[0033] Preferably, after dissolving, the method further includes a step of naturally cooling to room temperature.
[0034] Preferably, the precursor solution a is a clear and transparent solution.
[0035] According to an embodiment of the present invention, the molar volume ratio of the alkaline earth metal or transition metal source, the rare earth source, the long alkane chain organic acid and trioctylamine is (0.2-0.8) mmol: (0.005-0.3) mmol: (2-8) ml: (5-30) ml, preferably, the molar volume ratio of the alkaline earth metal or transition metal source, the rare earth source, the long alkane chain organic acid and trioctylamine is (0.3-0.6) mmol: (0.01-0.2) mmol: (3-6) ml: (10-25) ml, more preferably, the molar volume ratio of the alkaline earth metal or transition metal source, the rare earth source, the long alkane chain organic acid and trioctylamine is (0.35-0.55) mmol: (0.02-0.15) mmol: (4-5.5) ml: (12-18) ml.
[0036] According to an embodiment of the present invention, the alkaline earth metal or transition metal source is selected from alkaline earth metal salts or transition metal salts (hereinafter referred to as metal salts), and the anions in the metal salts are selected from one, two or more of acetate ions, halogen ions and oleate ions, wherein the halogen ions are F - , Cl - or Br - ; Preferably, the cation in the metal salt is selected from one, two or more of Mg, Zn, Zr and Sc.
[0037] According to an embodiment of the present invention, the rare earth source is selected from one, two or more of rare earth acetates, rare earth chlorides and rare earth nitrates, preferably rare earth acetates and rare earth chlorides, wherein the rare earth is selected from one or more of Yb, Er, Tm, Ho, Gd, Eu, Tb, Sm, Dy, Ce and Nd, preferably Yb, Er, Tm, Ho and Eu, more preferably co-doped with Yb and Er, wherein the molar ratio of Yb and Er is preferably (20-2)Yb:(0.1-4)Er.
[0038] According to an embodiment of the present invention, the long alkane chain organic acid is selected from one, two or more of octanoic acid, dodecanoic acid and oleic acid, and is preferably oleic acid.
[0039] According to an embodiment of the present invention, the preparation of the alkali metal fluoride precursor solution b in step 1) comprises: mixing an alkali metal source, a fluorine source and methanol, and stirring until dissolved.
[0040] Preferably, the alkali metal fluoride precursor solution b is a clear and transparent solution.
[0041] According to an embodiment of the present invention, in step 1), the dissolution ratio of the alkali metal source, the fluorine source and methanol is (0.5-5) mmol: (0.5-5) mmol: (5-15) ml.
[0042] According to an embodiment of the present invention, the alkali metal source is selected from one, two or more of alkali metal hydroxides, alkali metal oleates, alkali metal acetates, alkali metal fluorides, alkali metal fluorides, and alkali metal hydrofluorides, preferably one, two or three of alkali metal hydroxides, alkali metal acetates, and alkali metal fluorides, wherein the alkali metal is selected from one or two of lithium (Li), sodium (Na), potassium (K), rubidium (Rb) or cesium (Cs), preferably sodium (Na) and / or potassium (K).
[0043] According to an embodiment of the present invention, the fluorine source is selected from one or more of fluoride, hydrogen fluoride, and trifluoroacetate, preferably fluoride, hydrogen fluoride, such as ammonium fluoride.
[0044] The present invention also provides a rare earth inorganic nano bioluminescent imaging agent, which comprises the above nano material, preferably, comprises the above nano material after surface modification.
[0045] A method for preparing a rare earth inorganic nano bioluminescent developer comprises dissolving the above nano material to obtain the developer.
[0046] According to an embodiment of the present invention, the nanomaterial is first surface modified and then dissolved.
[0047] According to an embodiment of the present invention, the surface modification is achieved by an aqueous phase transfer method or a proton exchange method, such as a proton exchange method.
[0048] According to an embodiment of the present invention, the proton exchange method includes: reacting the nanomaterial with a water-soluble reagent.
[0049] According to an embodiment of the present invention, the water-soluble modified reagent is a hydrochloric acid ethanol solution or a mixed solution of trimethyloxonium tetrafluoroborate in N,N-dimethylformamide and cyclohexane, for example, a mixed solution of 15 ml of anhydrous ethanol and 80 μl of concentrated hydrochloric acid.
[0050] According to an embodiment of the present invention, the molar volume ratio of the nanomaterial to the water-soluble reagent is 0.05-0.3mmol:15ml. Preferably, the molar volume ratio of the nanomaterial to the water-soluble reagent is 0.1-0.2mmol:15ml, for example, 0.05mmol:15ml, 0.1mmol:15ml, 0.15mmol:15ml, 0.2mmol:15ml, 0.25mmol:15ml, and 0.3mmol:15ml.
[0051] For example, the nanomaterial is mixed with an acidic ethanol solution and reacted for 20-40 minutes.
[0052] Preferably, the reaction is carried out under ultrasound.
[0053] Preferably, after the reaction, the step of collecting the product by centrifugation for 10-20 min is further included. Preferably, the centrifugation time is 14-18 min, for example, 10 min, 12 min, 15 min, 16 min, 20 min.
[0054] According to an embodiment of the present invention, the molar volume ratio of the nanomaterial to the acidic ethanol solution is 0.05-0.3mmol:15ml, preferably, the molar volume ratio of the nanomaterial to the acidic ethanol solution is 0.1-0.2mmol:15ml, for example, 0.05mmol:15ml, 1mmol:15ml, 1.5mmol:15ml, 2mmol:15ml, 2.5mmol:15ml, 3mmol:15ml.
[0055] As an example, the specific steps of the proton exchange modification are: 0.05-0.3 mmol nanoparticles are dispersed in 15 ml of acidic ethanol solution A (a mixed solution of HCl and ethanol, pH = 1-2) and ultrasonicated for 20-40 minutes to remove surface ligands. After the reaction is completed, the product is collected by high-speed centrifugation for 10-20 minutes, and further dispersed and washed with acidic ethanol solution B (prepared by adding 5 μl of concentrated hydrochloric acid to 15 ml of anhydrous ethanol). After centrifugation and precipitation again, the obtained product is washed once with ethanol and can be dispersed in physiological saline, and sterile filtered to obtain a fluorescent imaging agent.
[0056] The present invention also provides an application of the fluorescent imaging agent for fluorescent labeling in vivo, preferably for specific imaging including but not limited to cancer, cardiovascular and cerebrovascular diseases.
[0057] The rare earth inorganic nanoluminescent material of the present invention is composed of a metal fluoride matrix (see Figure 1 and Fig.10 As shown) doped with rare earth ions and H + The crystal field perturbator is composed of a material that utilizes ultra-small H + As perturbers of the crystal field, the ions perturb the crystal field environment of the rare earth ions inside the crystal, partially relieving the parity forbidden effect of the rare earth ion 4f-4f transition caused by the high symmetry environment, thereby greatly improving the luminescence intensity of rare earth-doped inorganic nanomaterials while ensuring the original physical and chemical characteristics of the crystal.
[0058] The metal fluoride matrix material is a metal fluoride matrix material with obvious lattice gaps. The applicant unexpectedly found in the study that the metal fluoride matrix material with lattice gaps has F - Can be with H + Strong hydrogen bonding interactions are generated, and the lattice gaps can accommodate H+ , which is conducive to achieving H + Introduction into the lattice.
[0059] In order to successfully introduce H into the crystal + In the present invention, before the crystal synthesis growth, an appropriate amount of acidic solution is added to provide H + During the crystal growth process, the free H + will interact with the negative ions in the crystal (such as F - ) generates electrostatic action and gradually enters the interior of the lattice, thereby realizing H + Doping.
[0060] Beneficial Effects
[0061] (1) The present invention utilizes H + As a perturbant of the crystal field, it partially relieves the parity forbidden effect of the rare earth ion 4f-4f transition caused by the high symmetry environment in the crystal, thereby greatly improving the luminescence intensity of the crystal. + Compared with traditional rare earth inorganic nanoluminescent materials, rare earth doped inorganic nanoluminescent materials have better optical properties.
[0062] (2) H involved in the luminescent material of the present invention + The doping strategy has a wide range of applications and can use different acidic substances. It has obvious gain effects in both up-conversion and down-transfer luminescence modes for different rare earth ions and matrix materials.
[0063] (3) The synthesis conditions of the luminescent material of the present invention are easy to control and have good reproducibility. The prepared nanoparticles have good dispersibility and uniformity. + After doping, the original physical and chemical characteristics can be maintained.
[0064] (4) The luminescent material of the present invention does not introduce new toxic substances to the original rare earth inorganic nanomaterials. In particular, the luminescent material of the present invention does not introduce new toxic substances to the original rare earth inorganic nanomaterials. + The doping strategy can effectively ensure biological safety while greatly improving the luminescence performance of the material and expanding the application range of the material. BRIEF DESCRIPTION OF THE DRAWINGS
[0065] Figure 1 is the H of the orthorhombic NaMgF3:4%Yb / 1%Er nanoparticles in Example 1 of the present invention. + Schematic diagram of the implementation process of doping-enhanced luminescence.
[0066] Figure 2It is a transmission electron microscope image and a particle size distribution histogram of the hexagonal β-NaYF4:4%Yb / 1%Er nanoparticles in Comparative Example 1 of the present invention.
[0067] Figure 3 a is the orthorhombic phase NaMgF3:4%Yb / 1%Er / H nanoparticles in Example 1 of the present invention at different H + Doping concentration (H + =0, 1.6, 2.6, 3.1, 7.3, 14.7 mmol), Figure 3 b is the X-ray powder diffraction pattern of orthorhombic NaMgF3:4%Yb / 1%Er / H nanoparticles, Figure 3 c is high H + Doping concentration (H + =14.7mmol) in the orthorhombic phase of NaMgF3:4%Yb / 1%Er / H nanoparticles.
[0068] Figure 4 The orthorhombic phase KSc2F7:4%Yb / 1%Er / H nanoparticles in Example 2 of the present invention are + Doping concentration (H + =0, 5.24 mmol).
[0069] Figure 5 The tetragonal Na3ZrF7:20%Yb / 2%Er / H nanoparticles in Example 3 of the present invention are prepared under different conditions. + Doping concentration (H + =0, 5.24 mmol).
[0070] Figure 6 It is the orthorhombic NaMgF3:4%Yb / 1%Er / H(H + Transmission electron microscopy image of the nano fluorescent imaging agent with a doping concentration of 14.7 mmol).
[0071] Figure 7 The orthorhombic NaMgF3:4%Yb / 1%Er / H nanoparticles in Example 1 of the present invention are + Doping concentration (H + =0, 3.1, 14.7 mmol) 19 F spectrum.
[0072] Figure 8 The orthorhombic NaMgF3:4%Yb / 1%Er / H nanoparticles in Example 1 of the present invention are + Doping concentration (H +=0, 1.6, 2.6, 3.1, 7.3, 14.7 mmol) of F1s, Na1s, and Mg1s.
[0073] Fig. 9 a is the orthorhombic phase NaMgF3:4%Yb / 1%Er / H nanoparticles in Example 1 of the present invention at different H + Doping concentration (H + =0, 1.6, 2.6, 3.1, 7.3, 14.7 mmol) up-conversion emission spectra (excitation wavelength is 980 nm), Fig. 9 b is NaMgF3:4%Yb / 1%Er / H nanoparticles at different H + Comparison of luminescence intensity at different doping concentrations.
[0074] Fig.10 is H in Example 1 of the present invention + Upconversion luminescence comparison diagram of orthorhombic NaMgF3:4%Yb / 1%Er / H nanoparticles at a doping concentration of 14.7 mmol and hexagonal β-NaYF4:4%Yb / 1%Er nanoparticles of comparative example 1 (excitation wavelength is 980 nm).
[0075] Fig.11 a is the orthorhombic phase NaMgF3:4%Yb / 1%Er / H nanoparticles in Example 1 of the present invention at different H + Doping concentration (H + =0, 1.6, 2.6, 3.1, 7.3, 14.7 mmol) of near infrared emission spectra (excitation wavelength is 980 nm), Fig.11 b is NaMgF3:4%Yb / 1%Er / H nanoparticles at different H + Comparison of luminescence intensity at different doping concentrations.
[0076] Fig.12 a is the orthorhombic NaMgF3:4%Yb / 1%Er / H(H + =14.7mmol) nanoparticles in nude mice subcutaneously; Fig.12 b is a schematic diagram of the imaging effect.
[0077] Fig.13 a is a graph showing the weight change of mice in the ICR mouse toxicity test of the NaMgF3:4%Yb / 1%Er / H nano fluorescent imaging agent in Example 4 of the present invention, Fig.13 b is the diagram of organ coefficient changes after drug toxicity test.
[0078] Fig.14This is a tissue section diagram of the main organs of mice after the ICR mouse administration toxicity test of the NaMgF3:4%Yb / 1%Er / H nano fluorescent imaging agent in Example 4 of the present invention.
[0079] Fig.15 is the H of NaMgF3:4%Yb / 1%Er nanoparticles in Example 1 of the present invention. + Schematic diagram of the principle of doping-enhanced luminescence. DETAILED DESCRIPTION
[0080] The nano material of the present invention and its preparation method and application will be described in further detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies realized based on the above content of the present invention are encompassed within the scope that the present invention is intended to protect.
[0081] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.
[0082] The instruments involved in the following embodiments are as follows:
[0083] X-ray powder diffractometer (instrument model is MiniFlex2, manufacturer is Rigaku), transmission electron microscope (instrument model is TECNAI G2 F20, manufacturer is FEI), spectrometer (instrument model is FLS980, manufacturer is Edinburgh), CCD imaging system (manufacturer is ANDOR).
[0084] Comparative Example 1: Preparation of β-NaYF4:4%Yb / 1%Er Nanoparticles by Traditional High-Temperature Coprecipitation Method
[0085] At room temperature, yttrium acetate, ytterbium acetate and erbium acetate are weighed into a three-necked flask in a molar ratio of 0.475:0.02:0.005 mmol, and then oleic acid and octadecene (volume ratio of 5:16 ml) are added as solvents, and the mixture is heated to 150-155° C. under an inert atmosphere to completely dissolve the solids, and then naturally cooled to room temperature to obtain a clear solution; a methanol solution containing sodium hydroxide and ammonium fluoride (molar ratio of 1.25:2 mmol) is added to the solution, and the mixture is heated to 70-80° C. under an inert atmosphere, and kept warm until the methanol is completely removed, and then heated to 100-110° C., and kept warm until the water is completely removed, and then heated to 300° C. under an inert atmosphere, kept warm for 1 hour, and then naturally cooled to room temperature, precipitated and washed to obtain β-NaYF4:4%Yb / 1%Er nanoparticles.
[0086] See also Figure 2As shown, it is the morphology of the β-NaYF4:4%Yb / 1%Er nanoparticles prepared in this comparative example. The particle size of the nanoparticles obtained by statistics is 20.13nm.
[0087] Example 1: Preparation of H by improved high temperature coprecipitation method + Doped NaMgF3:4%Yb / 1%Er nanoparticles
[0088] At room temperature, a magnesium source, a ytterbium source, and an erbium source are weighed into a three-necked flask according to a molar ratio of 0.475:0.02:0.005 mmol, respectively, and oleic acid and trioctylamine (volume ratio of 5:15 ml) are added as solvents, and the temperature is raised to 150-155° C. under an inert atmosphere to completely dissolve the solid, and then naturally cooled to room temperature to obtain a clear solution; a methanol solution containing sodium hydroxide and ammonium fluoride (molar ratio of 1.5:1.5 mmol) is added to the above solution, and the temperature is raised to 70-80° C. under an inert atmosphere, and the temperature is kept until the methanol is completely removed, and the solution is cooled to room temperature. A condenser system is added to the gas outlet, and an acetic acid solution (0, 1.6, 2.6, 3.1, 7.3, 14.7 mmol) is injected under the protection of an inert atmosphere, and the temperature is quickly raised to 300-310° C., and the temperature is kept for 1 hour and then naturally cooled to room temperature, and precipitated and washed to obtain H + Doped orthorhombic NaMgF3:4%Yb / 1%Er / H nanoparticles.
[0089] See also Figure 3 a is a transmission electron micrograph of the NaMgF3:4%Yb / 1%Er / H nanoparticles prepared in this example. Figure 3 It can be seen that in different H + At different doping concentrations (0, 1.6, 2.6, 3.1, 7.3, and 14.7 mmol), the morphology of the nanoparticles remained rectangular, and the size of the nanoparticles increased with the increase of H + With the increase of doping concentration, they first decrease and then increase, and the sizes are 12.5, 6.7, 9.0, 12.3, 16.9, and 18.3 nm, respectively.
[0090] See also Figure 3 b is the X-ray powder diffraction pattern of the nanoparticles prepared in this example. Figure 3 b It can be seen that different H + The XRD diffraction peak positions of the nanoparticles at different doping concentrations are consistent with the JCPDS card 13-0303 of NaMgF3. At the same time, there are no obvious differences in the XRD diffraction peak shapes and diffraction peak positions among the samples.
[0091] See also Figure 3 As shown in b, the nanoparticles prepared in this example are imaged by high-angle annular dark field (HAADF-STEM) at high H+ At the doping concentration (HAc = 14.7 mmol), the rare earth ions Yb and Er can still be clearly detected inside the nanoparticles, indicating that at high H + At the doping concentration, Yb and Er can also be effectively doped into the internal lattice of the host crystal NaMgF3.
[0092] Example 2: Preparation of H by improved high temperature coprecipitation method + Doped KSc2F7:4%Yb / 1%Er nanoparticles
[0093] At room temperature, a scandium source, a ytterbium source, and an erbium source are weighed into a three-necked flask in a molar ratio of 0.475:0.02:0.005 mmol, respectively, and oleic acid and trioctylamine (volume ratio of 5:15 ml) are added as solvents, and the temperature is raised to 150-155° C. under an inert atmosphere to completely dissolve the solid, and then naturally cooled to room temperature to obtain a clear solution; a methanol solution containing potassium hydroxide and ammonium fluoride (molar ratio of 1:1.6 mmol) is added to the above solution, and the temperature is raised to 70-80° C. under an inert atmosphere, and the temperature is kept until the methanol is completely removed, and the solution is cooled to room temperature. A condenser system is added to the gas outlet, and an acetic acid solution (0, 5.24 mmol) is injected under the protection of an inert atmosphere, and the temperature is quickly raised to 300-310° C., and the temperature is kept for 1 hour, and the solution is naturally cooled to room temperature, and the solution is precipitated and washed to obtain H + Doped orthorhombic KSc2F7:4%Yb / 1%Er / H nanoparticles.
[0094] See also Figure 4 As shown, the X-ray powder diffraction (XRD) pattern of the nanoparticles prepared in this example is shown. Figure 4 It can be seen that different H + The XRD diffraction peak positions of the nanoparticles at different doping concentrations are consistent with the JCPDS card 77-1321 of KSc2F7.
[0095] Example 3: Preparation of H by improved high temperature coprecipitation method + Doped Na3ZrF7:20%Yb / 2%Er nanoparticles
[0096] At room temperature, a zirconium source, a ytterbium source, and an erbium source are weighed into a three-necked flask in a molar ratio of 0.585:0.15:0.015 mmol, respectively, and then oleic acid and trioctylamine (volume ratio of 5:15 ml) are added as solvents, and the temperature is raised to 150-155° C. under an inert atmosphere to completely dissolve the above solids, and then naturally cooled to room temperature to obtain a clear solution; a methanol solution containing sodium hydroxide and ammonium fluoride (molar ratio of 2.25:5.25 mmol) is added to the above solution, and the temperature is raised to 70-80° C. under an inert atmosphere, and the temperature is kept until the methanol is completely removed, and the solution is cooled to room temperature. A condenser system is added to the gas outlet, and an acetic acid solution (0, 5.24 mmol) is injected under the protection of an inert atmosphere, and the temperature is quickly raised to 300-310° C., and the temperature is kept for 1 hour, and the solution is naturally cooled to room temperature, and the solution is precipitated and washed to obtain H + Doped orthorhombic Na3ZrF7:20%Yb / 2%Er / H nanoparticles.
[0097] See also Figure 5 As shown, the X-ray powder diffraction (XRD) pattern of the nanoparticles prepared in this example is shown. Figure 5 It can be seen that different H + The XRD diffraction peak positions of the nanoparticles at different doping concentrations are consistent with the JCPDS card 74-0808 of Na3ZrF7.
[0098] Example 4: Preparation of NaMgF3:4%Yb / 1%Er / H Nano-imaging Agent
[0099] In order to obtain a water-soluble rare earth inorganic nano-imaging agent with biocompatibility, a common method is to remove the ligands / impurities on the surface by proton exchange. First, about 0.13mmol of the untreated nanocrystals in Example 1 were dispersed in 15ml of acidic ethanol solution A (a mixed solution of HCl and ethanol, pH=2) and ultrasonicated for 20 minutes to remove the surface ligands. After the reaction was completed, the product was collected by high-speed centrifugation for 10 minutes, and further dispersed and washed with acidic ethanol solution B (prepared by adding 5μl of concentrated hydrochloric acid to 15ml of anhydrous ethanol). After centrifugation and precipitation again, the obtained product was washed with ethanol once, and then it could be dispersed in physiological saline, and sterile filtered to obtain NaMgF3:4%Yb / 1%Er / H nano-fluorescent imaging agent.
[0100] See also Figure 6 As shown, the NaMgF3:4%Yb / 1%Er / H(H + Transmission electron microscopy image of the nano fluorescent imaging agent with a doping concentration of 14.7 mmol).
[0101] Test Example 1: H + Proof of successful introduction into NaMgF3:4%Yb / 1%Er crystal
[0102] Solid-state NMR spectroscopy confirmed that H + Successfully introduced into NaMgF3:4%Yb / 1%Er crystal
[0103] See also Figure 7 As shown, it is the solid NMR image of the nanoparticles prepared in Example 1. Figure 7 It can be seen that when there is H inside the nanoparticles + will cause the corresponding 19 The peak of the F spectrum shifts from Figure 7 It can be clearly observed that as H + Increase in doping concentration 19 The peak of the F spectrum will gradually shift to higher fields. In the nuclear magnetic spectrum, when the F spectrum shifts to higher fields, it indicates that the electron shielding effect is enhanced, and when it shifts to lower fields, it indicates that the electron shielding effect is weakened.
[0104] In the embodiment 1 shown, H was not introduced. + When 2 Ln 3+ Will replace 3 Mg 2+ In order to maintain charge balance, an octahedral vacancy consisting of F will appear, while Ln 3+ Relative to Mg 2+ With stronger electron-accepting ability, the surrounding F - On the contrary, after the introduction of H+ in the reaction, an H + and a Ln 3+ Will replace 2 Mg 2+ , H + Relative to Ln 3+ F - The deshielding effect of H is much weaker, so when H is introduced + This will cause the spectrum to move to higher fields. + successful introduction.
[0105] X-ray photoelectron spectroscopy confirmed that H + Successfully introduced into NaMgF3:4%Yb / 1%Er crystal
[0106] See also Figure 8 As shown, this is the X-ray photoelectron spectrum (XPS) of the nanoparticles prepared in Example 1. Figure 8 It can be seen that when there is H inside the nanoparticles + When H +The higher the doping amount, the more obvious the shift of binding energy to high field is, reaching up to 0.400, 0.598, and 0.232 eV, respectively. In XPS spectra, usually, the shift of binding energy to high field indicates that the element has lost electrons. The shift of binding energy to high field for F, Mg, and Na can just indicate that H + The electron loss effect of the three elements F, Mg, and Na caused by the introduction of + existence.
[0107] Test Example 2: H + Verification of improved luminescence performance by doping NaMgF3:4%Yb / 1%Er
[0108] Verification of the improvement of up-conversion luminescence performance in the visible light region:
[0109] At a power density of 30 W cm -2 Under the excitation of 980nm laser, all samples in Example 1 have Er 3+ The characteristic upconversion emission ( Fig. 9 a), and exhibits a high red-green ratio (R / G) luminescence characteristic, i.e. 4 F 9 / 2 → 4 I 15 / 2 The red light caused by the transition is significantly stronger than 2 H 11 / 2 , 4 S 3 / 2 → 4 I 15 / 2 The difference is that with the H + As the amount added increases, the overall luminescence intensity of the sample in Example 1 increases accordingly.
[0110] See also Fig. 9 As shown in b, the luminescence intensity of the sample is obtained by integrating the entire spectral region (400-750 nm), and the luminescence intensity of NaMgF3:4%Yb / 1%Er in H + The luminescence intensity and H + When the doping amount is 0mmol, the luminescence intensity of NaMgF3:4%Yb / 1%Er nanocrystals increases with H + The trend of the amount added. Fig. 9 It can be clearly seen in b that as H + As the amount of H added continued to increase, the luminescence intensity of the sample in Example 1 also continued to increase. + (14.7mmol) after NaMgF3:4%Yb / 1%Er / H has a luminescent intensity that is not doped with H+ 675 times.
[0111] Comparison of upconversion spectra and quantum yields of NaMgF3:Yb / Er / H and β-NaYF4:Yb / Er:
[0112] At a power density of 30 W cm -2 Under the excitation of a 980nm laser, the NaYF4:4%Yb / 1%Er in Comparative Example 1 exhibited dazzling green light emission, and the NaMgF3:4%Yb / 1%Er / H in Example 1 exhibited dazzling red light emission. The emission spectrum is shown in FIG. Fig.10 In the red light region (600-750 nm), the integrated intensity of the emission spectrum of NaMgF3:4%Yb / 1%Er / H in Example 1 is 4.8 times that of β-NaYF4:4%Yb / 1%Er in Comparative Example 1, and the red light quantum yield of NaMgF3:4%Yb / 1%Er / H in Example 1 is 0.1%, which is 1.7 times that of β-NaYF4:4%Yb / 1%Er in Comparative Example 1.
[0113] Verification of improved luminescence performance in the down-shifted near-infrared region:
[0114] Under 980nm xenon lamp excitation, all samples in Example 1 have Er 3+ Characteristic down-shifted near-infrared emission ( Fig.11 a), which corresponds to 4 I 13 / 2 → 4 I 15 / 2 The emission peak caused by the transition is located in the near-infrared light at 1532nm. + As the amount of addition increases, the near-infrared luminescence intensity of the entire sample in Example 1 increases accordingly. Fig.11 As shown in b, the near-infrared luminescence intensity of the sample is obtained by integrating the entire near-infrared spectral region (1400-1620 nm), and the near-infrared luminescence intensity of NaMgF3:4%Yb / 1%Er in H + The near-infrared luminescence intensity and H + When the doping amount is 0mmol, a comparison chart is made. Fig.11 It can be clearly seen in b that as H + As the amount of H added continued to increase, the near-infrared luminescence intensity of the nanocrystals in Example 1 also continued to increase. + After adding (14.7mmol), the near-infrared luminescence intensity of NaMgF3:4%Yb / 1%Er / H in Example 1 is the initial one without H doping. + 259.4 times of that.
[0115] Test Example 3: Bioluminescent Imaging Effect of NaMgF3:4%Yb / 1%Er / H Nano-imaging Agent
[0116] like Fig.12 As shown in a, nude mice were subcutaneously injected with a trace amount of NaMgF3:4%Yb / 1%Er / H (H + The doping concentration is 14.7mmol) nano-imaging agent (50mg / mL), and the imaging is excited by 980nm excitation light under the CCD imaging system. Fig.12 As shown in b, obvious upconversion fluorescence can be observed at the location where the nanoparticles were injected.
[0117] Test Example 4: Biosafety of NaMgF3:4%Yb / 1%Er / H Nano-imaging Agent
[0118] Cytotoxicity test: (using MTT colorimetry and human embryonic kidney 293T cells)
[0119] As shown in Table 1, the NaMgF3:4%Yb / 1%Er / H (H + The nano-imaging agent with a doping concentration of 14.7 mmol) can maintain normal cell activity in human embryonic kidney 293T cells within the concentration range of 0-0.5 mg / mL, indicating that the nano-crystal has low cytotoxicity.
[0120] Table 1. Cytotoxicity test results of NaMgF3:Yb / Er / H
[0121]
[0122] Mouse toxicity test
[0123] like Fig.13 As shown in a and 13b, within the 0-40 mg / kg dosage range, the changes in body weight and organ coefficients of male and female mice were not significantly different from those of the control group, and they developed normally until maturity. During the observation period, no abnormalities were observed in their appearance, nervous system, respiratory and circulatory system, urogenital system, behavioral activities, and food and water intake. Fig.14 As shown, no macroscopic lesions were found during the autopsy, and no abnormal lesions were found in the heart, liver, lung, kidney, and intestinal tissues of all animals by pathological histological examination.
[0124] The above is an explanation of the embodiments of the present invention. However, the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A H + The method for synthesizing a rare earth inorganic nano-luminescent material with doping-enhanced luminescence comprises the following steps: 1) preparing an alkaline earth metal and rare earth mixed precursor solution a and an alkali metal fluoride precursor solution b; 2) Under an inert atmosphere, an alkaline earth metal and rare earth mixed precursor solution a and an alkali metal fluoride precursor solution b are mixed, the solvent in the alkali metal fluoride precursor solution b is removed, and the acidic solution is injected into the aforementioned solution, the temperature is raised to 270-340 °C, and the temperature is kept for 0.5-1.5 h to react, and the solution is cooled and centrifuged to obtain a precipitate to obtain H + Rare earth doped inorganic nanoluminescent materials; The cation in the alkaline earth metal is selected from Mg; the rare earth in the alkaline earth metal and rare earth mixed precursor solution a is co-doped with Yb and Er; The alkali metal in the alkali metal fluoride precursor solution b is selected from Na.
2. The synthesis method according to claim 1, characterized in that In step 2), the reaction temperature is 290-320° C. and the insulation time is 45-100 min.
3. The synthesis method according to claim 1, characterized in that The acidic solution is selected from one, two or more of acetic acid, hydrochloric acid, phenylcyclic acid and formic acid.
4. The synthesis method according to any one of claims 1 to 3, characterized in that The preparation of the alkaline earth metal and rare earth mixed precursor solution a in step 1) includes: mixing a rare earth source, a long alkane chain organic acid, trioctylamine, and an alkaline earth metal source until dissolved to obtain an alkaline earth metal and rare earth mixed precursor solution a.
5. The synthesis method according to claim 4, characterized in that The mixing until dissolved includes heating to 140-165° C. under the protection of an inert atmosphere, and stirring for 0.3-1 h until dissolved.
6. The synthesis method according to claim 4, characterized in that The molar volume ratio of the alkaline earth metal source, the rare earth source, the long alkane chain organic acid and trioctylamine is (0.2-0.8) mmol: (0.005-0.3) mmol: (2-8) ml: (5-30) ml.
7. The synthesis method according to any one of claims 1 to 3, characterized in that The step 1) of preparing the alkali metal fluoride precursor solution b comprises: mixing an alkali metal source, a fluorine source and methanol, and stirring until dissolved.
8. The synthesis method according to claim 7, characterized in that In step 1), the dissolution ratio of the alkali metal source, the fluorine source and methanol is (0.5-5) mmol: (0.5-5) mmol: (5-15) ml.
9. H prepared by the method according to any one of claims 1 to 8 + The rare earth inorganic nanoluminescent material with enhanced ion doping is characterized by: The chemical formula of the nano luminescent material is NaMgF3:Yb / Er / H.
10. A rare earth inorganic nano bioluminescent imaging agent, comprising the nano luminescent material according to claim 9.
11. A method for preparing a rare earth inorganic nano bioluminescent imaging agent, comprising dissolving the nano luminescent material according to claim 9.
12. The preparation method according to claim 11, characterized in that: The nanometer luminescent material is first reacted with a water-soluble modification agent to remove the surface ligand of the nanometer luminescent material, and then dissolved to obtain the nanometer luminescent material.
13. The preparation method according to claim 12, characterized in that: The water-soluble modifying reagent is an acidic ethanol solution.
14. The preparation method according to claim 12, characterized in that: The molar volume ratio of the nano luminescent material to the water-soluble reagent is 0.05-0.3 mmol:15 ml.
15. The preparation method according to any one of claims 12 to 14, characterized in that: The reaction includes mixing the nano luminescent material with a water-soluble reagent and reacting for 20-40 minutes.
Citation Information
Patent Citations
Method for preparing tubular enhanced upconversion rare-earth nano fluorescent material
CN102965111A
Method for improving luminous intensity of rare earth ion co-doped up-conversion nano material
CN105238405A
Rare-earth oxyfiuoride nanometer material, and preparation method and application thereof
CN105505392A
Method for enhancing up-conversion luminescent intensity of rare earth-doped scandium tungstate
CN105694882A
Method for improving fluorescence efficiency of impurity enhancement type tombarthite upconversion material
CN107892913A
